RNA networks in ovarian cancer

Anastasia Malek1

  • 1Laboratory of Oncoendocrinology, NN Petrov Institute of Oncology, St. Petersburg, Russia.

Insights

Ovarian cancer development involves changes in cellular RNA expression, including noncoding RNAs. This review covers methods for studying these RNA alterations in ovarian cancer research.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian cancer development is linked to altered cellular RNA expression.
  • Gene expression changes significantly correlate with ovarian cancer characteristics.
  • Noncoding RNAs are increasingly recognized for their role in cancer biology.

Purpose of the Study:

  • To review methodological approaches for studying RNA alterations in ovarian cancer.
  • To provide an overview of techniques applicable to both protein-coding and noncoding RNAs.

Main Methods:

  • Review of existing literature and methodologies.
  • Focus on techniques for analyzing gene and noncoding RNA expression.
  • Comparative analysis of different study approaches.

Main Results:

  • Established methods exist for analyzing protein-coding RNA alterations.
  • Emerging techniques are available for noncoding RNA analysis in ovarian cancer.
  • A comprehensive understanding requires studying both RNA types.

Conclusions:

  • Methodological advancements facilitate the study of RNA expression in ovarian cancer.
  • Investigating both coding and noncoding RNAs is crucial for understanding ovarian cancer.
  • Further research into RNA-based biomarkers and therapeutics is warranted.

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...